Compare BDSX & SRFM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | BDSX | SRFM |
|---|---|---|
| Founded | 2005 | 2011 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Precision Instruments | Transportation Services |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 107.5M | 110.4M |
| IPO Year | 2020 | 2023 |
| Metric | BDSX | SRFM |
|---|---|---|
| Price | $15.28 | $1.35 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 5 | 3 |
| Target Price | ★ $32.50 | $3.25 |
| AVG Volume (30 Days) | 73.6K | ★ 4.6M |
| Earning Date | 05-04-2026 | 05-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 45.69 |
| EPS | ★ N/A | N/A |
| Revenue | $88,499,000.00 | ★ $106,557,000.00 |
| Revenue This Year | $25.26 | $25.90 |
| Revenue Next Year | $19.15 | $20.72 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 24.08 | N/A |
| 52 Week Low | $0.25 | $1.01 |
| 52 Week High | $20.21 | $9.35 |
| Indicator | BDSX | SRFM |
|---|---|---|
| Relative Strength Index (RSI) | 60.89 | 55.33 |
| Support Level | $12.77 | $1.05 |
| Resistance Level | $16.26 | $1.46 |
| Average True Range (ATR) | 1.22 | 0.12 |
| MACD | 0.61 | 0.05 |
| Stochastic Oscillator | 86.52 | 57.89 |
Biodesix Inc is a diagnostic solutions company with a focus on lung disease. The Company has a single operating segment focused on providing diagnostic testing services to customers. It provides biopharmaceutical companies with services that include diagnostic research, clinical trial testing, and the discovery, development, and commercialization of companion diagnostics. The revenue is derived from two sources: providing diagnostic testing services associated with blood-based lung and COVID tests; and providing biopharmaceutical companies with services generally provided outside the clinical setting and governed by individual contracts with third parties, as well as the development and commercialization of companion diagnostics.
Surf Air Mobility Inc is a regional air mobility platform operating commuter airlines in the United States and expanding an on-demand charter marketplace for passengers in the U.S. and globally. It is also focused on developing a proprietary aviation software, aircraft electrification powertrain technology and services to enable electrification across the regional air mobility sector. The company operates in a single reportable segment, Air Mobility. The Air Mobility segment derives revenue from operating scheduled commercial air service flights, which are sold to the public mainly on a per-seat basis; through subsidized EAS revenue awards from the Department of Transportation; and by operating on-demand flights for customers on an ad-hoc, by request basis.